Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Breast cancer treatment: perspectives on the oncolytic virus

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jul 13, 2024 3:11pm

77 Views

Post# 36131690

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Breast cancer treatment: perspectives on the oncolytic virus

And what the heck are you talking about with the Epstein files?!....Trump has no say on whether or not the Epstein files are released!...That is simply more lies from the corrupt media attacking Trump....he has nothing to hide, because as I tried(with apparently no success) to tell you before, if there was one tiny molecule of criminality by Trump in the Epstein files, it would be pasted front and centre on every hack rag in the world.

<< Previous

Bullboard Posts

Next >>

Rick Rule’s election insights: Gold, USD, and Canadian gas